Patel Gautam bought AMRX
May 7, 2026 · Form 4 insider transaction
Patel Gautam bought 34,819 shares of Amneal Pharmaceuticals, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
34,819
Price
N/A
Total value
N/A
InsiderPatel Gautam
Role—
SecurityClass A Common Stock
Transaction codeM: Option exercise
Transaction dateMay 7, 2026
Filing dateMay 8, 2026
Shares owned after1,643,963
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.